Congo trial of Ebola treatments switches to focus on two drugs

A clinical trial of four potential Ebola treatments in Congo has been narrowed to focus on two of the experimental drugs – Regeneron's REGN-EB3 and a monoclonal antibody called mAb114 – after they showed encouraging results, scientists leading the trial said on Monday. Reuters Health News